BAK BAK
Company Profile ↓Company Overview
BAK (BAK) is a publicly traded company listed on with a market capitalization of $1.80B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 61.2%, reflecting efficient use of shareholder capital.
Recent Developments
- Dec 2025 Revenue of $70.72B (-8.6% YoY); net profit $-9.88B.
- Trailing 12 Months Year-on-year growth — revenue -8.6%.
- 5-Year Trend Long-term compounding — revenue CAGR -9.8%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -9.85% |
| 1 Year: | -8.65% |
Stock Price Performance
| 1 Year: | -26.14% |
| 6 Months: | -37.40% |
| 3 Months: | -41.45% |
| 1 Month: | -5.83% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- Death Cross8d ago
- RSI (14)35.47 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 61.2%.
CONS
- Revenue declined at -9.8% CAGR over 5 years.
- Trading 55.0% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 19.46B | 17.86B | 17.30B | 16.10B | 15.49B |
| Cost of Revenue | - | 18.15B | 17.50B | 16.86B | 16.65B | 14.39B |
| Gross Profit | - | 1.31B | 362.00M | 436.00M | -552.00M | 1.10B |
| Operating Expenses | - | 1.31B | 1.32B | 1.23B | -665.00M | 1.32B |
| Operating Income | - | 1.00M | -958.00M | -798.00M | 113.00M | -217.00M |
| EBITDA | - | 3.30B | 2.36B | 93.00M | 2.12B | 3.46B |
| Interest Expense | - | 1.29B | 1.65B | 1.60B | 1.50B | 1.33B |
| Pretax Income | - | 816.00M | -530.00M | -2.59B | -540.00M | 953.00M |
| Tax Provision | - | 184.00M | -140.00M | -2.42B | 10.49B | -293.00M |
| Net Income | - | 698.00M | -267.00M | -26.00M | -10.29B | 1.45B |
| Diluted EPS | - | 1.75 | -0.67 | -0.07 | -25.81 | 3.63 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 96.52B | 70.57B | 77.41B | 70.72B |
| Cost of Revenue | - | 85.16B | 67.55B | 71.41B | 69.16B |
| Gross Profit | - | 11.36B | 3.02B | 6.00B | 1.56B |
| Operating Expenses | - | 5.25B | 4.77B | 6.99B | 3.20B |
| Operating Income | - | 6.11B | -1.75B | -990.00M | -1.64B |
| EBITDA | - | 8.11B | 3.26B | -7.35B | 7.08B |
| Interest Expense | - | 3.33B | 4.25B | 5.44B | 5.25B |
| Pretax Income | - | 47.00M | -6.19B | -17.73B | -2.85B |
| Tax Provision | - | 868.00M | -1.30B | -5.68B | 8.12B |
| Net Income | - | -336.00M | -4.58B | -11.32B | -9.88B |
| Diluted EPS | - | -0.84 | -11.49 | -28.40 | -24.79 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 88.05B | 91.74B | 101.58B | 81.88B |
| Current Assets | - | 34.46B | 37.44B | 37.04B | 30.45B |
| Cash & Equivalents | - | 12.47B | 14.19B | 14.99B | 10.50B |
| Inventory | - | 13.91B | 12.38B | 13.47B | 10.42B |
| Receivables | - | 3.23B | 2.91B | 3.56B | 3.46B |
| Total Liabilities | - | 81.94B | 88.46B | 105.85B | 98.38B |
| Current Liabilities | - | 24.19B | 24.49B | 28.27B | 40.22B |
| Long Term Debt | - | 47.33B | 53.21B | 66.28B | 46.39B |
| Total Debt | - | 53.83B | 59.91B | 73.72B | 71.32B |
| Total Equity | - | 7.32B | 3.99B | -4.78B | -16.15B |
| Shares Outstanding | - | 796.97M | 796.97M | 796.97M | 796.97M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 8.95B | -2.27B | 2.44B | -4.20B |
| Investing Cash Flow | - | -4.95B | -4.53B | -3.48B | -2.95B |
| Financing Cash Flow | - | 225.00M | 8.87B | 470.00M | 3.18B |
| Capital Expenditure | - | -4.85B | -4.53B | -3.76B | -3.13B |
| Free Cash Flow | - | 4.10B | -6.80B | -1.32B | -7.33B |
| Net Change in Cash | - | 4.23B | 2.08B | -581.00M | -3.97B |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 11.8% | 4.3% | 7.7% | 2.2% |
| Operating Margin % | - | 6.3% | -2.5% | -1.3% | -2.3% |
| Net Margin % | - | -0.3% | -6.5% | -14.6% | -14.0% |
| ROE % | - | -4.6% | -114.7% | 236.7% | 61.2% |
| ROCE % | - | 9.6% | -2.6% | -1.4% | -3.9% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for BAK
Braskem (BAK) Expected to Post Earnings on Wednesday - MarketBeat
<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxNWENCYm0wMmtOU1o1LUczS053TlVKYWo4TGZYY1dVNTJRcUtPVVhWNnBwREZwVDYzRTA0dXlqeU4wZlBaMTdZVEZKTEgzckZkVWVkMHNMNWhhSjFLM0FINlNSa3FUS19OMnJmLUNqd3o5enRNYW9LZ3FZbkhmUkJ4c2RkSmxETWZvQ1NBQ3…
Braskem (NYSE: BAK) explains creditor talks and 60-day court protection - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxNOFRxNWNMT0RVUGhxaGwxTDlSMHhGd20wXy1ybU9LMkI4Nl9Na3JxcGc0NExlVXBrQ2RwM3haN1ljLXhqZlpHcTZKb0lhQ2hwRWd4UUlCenhlb3J3OWRzeGRNcnBHcUk4SnBVRkNjTEIzNmZCREtkcVdYd2Z4SlBrdnFvMUVnbEVxVzB1RH…
Is Braskem (BAK) Stock Outpacing Its Basic Materials Peers This Year? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxNajJVWF9oVUJKU3RidWcyaDhwUHZCcnF1ZjRiWE9FZkl6THV6WGxidDlRUlhaLUNCdnFEVHQzRkhmUE16eW40T1ZaSEN4YUhKTTdzRVdIc196STg1dWg2OWZNdE5ZeVZITTQwR1FmbEZUUll1WGt2ZE5VcU02VE1pZzhZX1FRY1FLUGE2VT…
Braskem Clarifies Status of Debt Talks and Court-Backed Mediation - theglobeandmail.com
<a href="https://news.google.com/rss/articles/CBMi5gFBVV95cUxPVEVkTnUzT0NjeEZpUjdPS0Y0dVVHWHNWWTBneTdkV1o3Y0tIZGFGYjk0cDc1eTczdVRYSUNIQjdyZG5QNU41a1gzWjE4NUZyMUtZMW45OTR2OFFHWkNCS3dNSnlxS2JrWlYzSmRCQTNxaExMazc2NHB2ZGhZQ29CUWlIOFphOEJjVGRhbT…
Is Braskem (BAK) Outperforming Other Basic Materials Stocks This Year? - qz.com
<a href="https://news.google.com/rss/articles/CBMiigFBVV95cUxOU3ZBdllYWFBMd2l4V3M5VnRVb0JDWlAtSmtJWUFybk5KRVZ1VVVXSllXbC15THdWZ2VDZkd5NEM4SGFWVkphdWlqaU10Y1VIV05qTXREa3lKU2ljTDhtNk8zZkdCRnplbHA2ZEJSOThSQ0hsT1RqX1hHSDY2T0p2Smx4RkZTSW41dWc?oc…
Braskem (BAK) Faces Legal Challenges, Shares Decline - GuruFocus
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxPNERLa0djQ0paTlpOZ1dETFFaU2FONTdmemFtNVdPWWdNZzJoSFhoNlZyV2w0NFZyYXVnbUZIMFB6Z3QxRDdiM3lfZ2t1OEJSY19rMl81d1FEcG9SX1pSeHRQd3FyLUZDdE55Wl9ia2tXZmN0c21DSUk3TldsaU9lc0VHUXJzQ2QxcXlKd2…
BAK — Frequently Asked Questions
What is the current share price of BAK?
As of 2026-08-05 17:25 PDT, BAK trades at $2.26 on NASDAQ/NYSE. Its 52-week range is $2.26 to $5.02.
What is the market capitalisation of BAK?
BAK has a market capitalisation of $1.80B on NASDAQ/NYSE.
What is the P/E ratio of BAK?
BAK trades at a trailing price-to-earnings (P/E) ratio of -0.09. Its price-to-book (P/B) ratio is -0.11.
What is the return on equity (ROE) of BAK?
BAK has a return on equity (ROE) of 61.19%. Its return on capital employed (ROCE) is -3.94%.
Is BAK a good stock to buy?
This page provides a data-driven analysis of BAK, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.